Skip to Main Content

Paper Details

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study.
Ann Rheum Dis
72
2022
Author NameAffiliation
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • 1 - 1

Datasets

Release 1.2